designation
-
Sleep Health
FDA Grants Fast Track Designation to Lu AH69593 for the Treatment of Narcolepsy
The United States Food and Drug Administration (FDA) has officially granted Fast Track designation to Lu AH69593, an investigational oral…
Read More » -
Sleep Health
FDA Grants Fast Track Designation to Lundbeck’s Lu AH69593 for the Treatment of Narcolepsy
The pharmaceutical industry and the sleep medicine community are closely monitoring a significant regulatory development as H. Lundbeck A/S (Lundbeck)…
Read More »
